California-based Cytek Biosciences Inc. has pocketed $120 million in a Series D round funding co-led by the US investment manager RA Capital and the Asia focused private equity firm Hillhouse Capital, per a company statement on Friday.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
